Upload
aurimas-racas
View
243
Download
0
Embed Size (px)
Citation preview
Solution by LT from LV
Agenda
12/09/09 2
Generic drugs producer Generic drugs & ingredients producer
Revenues by countries
Generic drugs producerGeneric drugs &
ingredients producer
Product origin Product types
Intra-industryVertical (value chain)
Horizontal (competitors)Both Internal &Market Drivers
Previous Sanitas Mergers
Previous Sanitas Mergers
HB and Jelfa deals are identical
Capacity building/consolidation
Product and market extension
Geographic roll-up
Same cost and revenues synergies
All mergers operational
HB Slovak
Jelfa
Homeofarm
Reactions
Reactions
12/09/098
Possible anti-trust case
Maximum market share in a country
Excessive bargaining power over distributorsNone, as drug stores chains are also very consolidated
The consolidated market share will not exceed 10% in any of the countries
Attention from Competition Council is highly unlikely
Proposed Integration
Organizational integration
Revenues benefits
Cost benefits
Questions are welcome!12/09/09 14